301 related articles for article (PubMed ID: 28529043)
1. The impact of the halogen bonding on D
Partyka A; Kurczab R; Canale V; Satała G; Marciniec K; Pasierb A; Jastrzębska-Więsek M; Pawłowski M; Wesołowska A; Bojarski AJ; Zajdel P
Bioorg Med Chem; 2017 Jul; 25(14):3638-3648. PubMed ID: 28529043
[TBL] [Abstract][Full Text] [Related]
2. New arylpiperazinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and dihydro[1,3]oxazolo[2,3-f]purinedione targeting the serotonin 5-HT1A /5-HT2A /5-HT7 and dopamine D2 receptors.
Chłoń-Rzepa G; Zagórska A; Bucki A; Kołaczkowski M; Pawłowski M; Satała G; Bojarski AJ; Partyka A; Wesołowska A; Pękala E; Słoczyńska K
Arch Pharm (Weinheim); 2015 Apr; 348(4):242-53. PubMed ID: 25773907
[TBL] [Abstract][Full Text] [Related]
3. Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT₁A/5-HT₂A/5-HT₇ and dopamine D₂/D₃ receptors.
Zajdel P; Marciniec K; Maślankiewicz A; Grychowska K; Satała G; Duszyńska B; Lenda T; Siwek A; Nowak G; Partyka A; Wróbel D; Jastrzębska-Więsek M; Bojarski AJ; Wesołowska A; Pawłowski M
Eur J Med Chem; 2013 Feb; 60():42-50. PubMed ID: 23279866
[TBL] [Abstract][Full Text] [Related]
4. Quinoline- and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor-5-HT1A/5-HT2A/5-HT7 and D2/D3/D4-agents: the synthesis and pharmacological evaluation.
Zajdel P; Marciniec K; Maślankiewicz A; Satała G; Duszyńska B; Bojarski AJ; Partyka A; Jastrzębska-Więsek M; Wróbel D; Wesołowska A; Pawłowski M
Bioorg Med Chem; 2012 Feb; 20(4):1545-56. PubMed ID: 22277589
[TBL] [Abstract][Full Text] [Related]
5. Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent.
Czopek A; Kołaczkowski M; Bucki A; Byrtus H; Pawłowski M; Kazek G; Bojarski AJ; Piaskowska A; Kalinowska-Tłuścik J; Partyka A; Wesołowska A
Bioorg Med Chem; 2015 Jul; 23(13):3436-47. PubMed ID: 25936259
[TBL] [Abstract][Full Text] [Related]
6. New 8-aminoalkyl derivatives of purine-2,6-dione with arylalkyl, allyl or propynyl substituents in position 7, their 5-HT1A, 5-HT2A, and 5-HT7 receptor affinity and pharmacological evaluation.
Chłoń-Rzepa G; Zmudzki P; Satała G; Duszyńska B; Partyka A; Wróbel D; Jastrzębska-Więsek M; Wesołowska A; Bojarski AJ; Pawłowski M; Zajdel P
Pharmacol Rep; 2013; 65(1):15-29. PubMed ID: 23563020
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Carboxamide/Sulfonamide Replacement in Arylpiperazinylalkyl Derivatives on Activity to Serotonin and Dopamine Receptors.
Kowalski P; Śliwa P; Satała G; Kurczab R; Bartos I; Zuchowicz K
Arch Pharm (Weinheim); 2017 Oct; 350(10):. PubMed ID: 28846141
[TBL] [Abstract][Full Text] [Related]
8. HBK-7 - A new xanthone derivative and a 5-HT1A receptor antagonist with antidepressant-like properties.
Pytka K; Kazek G; Siwek A; Mordyl B; Głuch-Lutwin M; Rapacz A; Olczyk A; Gałuszka A; Waszkielewicz A; Marona H; Sapa J; Filipek B; Zygmunt M
Pharmacol Biochem Behav; 2016; 146-147():35-43. PubMed ID: 27132236
[TBL] [Abstract][Full Text] [Related]
9. Towards novel 5-HT7versus 5-HT1A receptor ligands among LCAPs with cyclic amino acid amide fragments: design, synthesis, and antidepressant properties. Part II.
Canale V; Kurczab R; Partyka A; Satała G; Witek J; Jastrzębska-Więsek M; Pawłowski M; Bojarski AJ; Wesołowska A; Zajdel P
Eur J Med Chem; 2015 Mar; 92():202-11. PubMed ID: 25555143
[TBL] [Abstract][Full Text] [Related]
10. In the search for a lead structure among series of potent and selective hydantoin 5-HT
Latacz G; Lubelska A; Jastrzębska-Więsek M; Partyka A; Sobiło A; Olejarz A; Kucwaj-Brysz K; Satała G; Bojarski AJ; Wesołowska A; Kieć-Kononowicz K; Handzlik J
Chem Biol Drug Des; 2017 Dec; 90(6):1295-1306. PubMed ID: 28886235
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antidepressant activity of a series of arylalkanol and aralkyl piperazine derivatives targeting SSRI/5-HT
Gu ZS; Xiao Y; Zhang QW; Li JQ
Bioorg Med Chem Lett; 2017 Dec; 27(24):5420-5423. PubMed ID: 29138029
[TBL] [Abstract][Full Text] [Related]
12. (S)-(-)-4-[4-[2-(isochroman-1-yl)ethyl]-piperazin-1-yl] benzenesulfonamide, a selective dopamine D4 antagonist.
TenBrink RE; Bergh CL; Duncan JN; Harris DW; Huff RM; Lahti RA; Lawson CF; Lutzke BS; Martin IJ; Rees SA; Schlachter SK; Sih JC; Smith MW
J Med Chem; 1996 Jun; 39(13):2435-7. PubMed ID: 8691438
[No Abstract] [Full Text] [Related]
13. Design, synthesis and evaluation of benzo[a]thieno[3,2-g]quinolizines as novel l-SPD derivatives possessing dopamine D1, D2 and serotonin 5-HT1A multiple action profiles.
Li Z; Huang J; Sun H; Zhou S; Guo L; Zhou Y; Zhen X; Liu H
Bioorg Med Chem; 2014 Nov; 22(21):5838-46. PubMed ID: 25308766
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of 2-fluoro and 3-trifluoromethyl-phenyl-piperazinylalkyl derivatives of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione as potential antidepressant agents.
Zagórska A; Bucki A; Kołaczkowski M; Siwek A; Głuch-Lutwin M; Starowicz G; Kazek G; Partyka A; Wesołowska A; Słoczyńska K; Pękala E; Pawłowski M
J Enzyme Inhib Med Chem; 2016; 31(sup3):10-24. PubMed ID: 27353547
[TBL] [Abstract][Full Text] [Related]
15. Novel arylsulfonamide derivatives with 5-HT₆/5-HT₇ receptor antagonism targeting behavioral and psychological symptoms of dementia.
Kołaczkowski M; Marcinkowska M; Bucki A; Pawłowski M; Mitka K; Jaśkowska J; Kowalski P; Kazek G; Siwek A; Wasik A; Wesołowska A; Mierzejewski P; Bienkowski P
J Med Chem; 2014 Jun; 57(11):4543-57. PubMed ID: 24805037
[TBL] [Abstract][Full Text] [Related]
16. Novel multi-target azinesulfonamides of cyclic amine derivatives as potential antipsychotics with pro-social and pro-cognitive effects.
Zajdel P; Kos T; Marciniec K; Satała G; Canale V; Kamiński K; Hołuj M; Lenda T; Koralewski R; Bednarski M; Nowiński L; Wójcikowski J; Daniel WA; Nikiforuk A; Nalepa I; Chmielarz P; Kuśmierczyk J; Bojarski AJ; Popik P
Eur J Med Chem; 2018 Feb; 145():790-804. PubMed ID: 29407591
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antidepressant-like activity of novel aralkyl piperazine derivatives targeting SSRI/5-HT
Gu ZS; Zhou AN; Xiao Y; Zhang QW; Li JQ
Eur J Med Chem; 2018 Jan; 144():701-715. PubMed ID: 29291438
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of antidepressant-like activity of some 4-substituted 1-(2-methoxyphenyl)piperazine derivatives.
Waszkielewicz AM; Pytka K; Rapacz A; Wełna E; Jarzyna M; Satała G; Bojarski A; Sapa J; Żmudzki P; Filipek B; Marona H
Chem Biol Drug Des; 2015 Mar; 85(3):326-35. PubMed ID: 25048712
[TBL] [Abstract][Full Text] [Related]
19. Structural determinants influencing halogen bonding: a case study on azinesulfonamide analogs of aripiprazole as 5-HT
Marciniec K; Kurczab R; Książek M; Bębenek E; Chrobak E; Satała G; Bojarski AJ; Kusz J; Zajdel P
Chem Cent J; 2018 May; 12(1):55. PubMed ID: 29748774
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships and molecular studies of novel arylpiperazinylalkyl purine-2,4-diones and purine-2,4,8-triones with antidepressant and anxiolytic-like activity.
Zagórska A; Kołaczkowski M; Bucki A; Siwek A; Kazek G; Satała G; Bojarski AJ; Partyka A; Wesołowska A; Pawłowski M
Eur J Med Chem; 2015 Jun; 97():142-54. PubMed ID: 25965777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
